Stability of epigenetic structures in ART children
Project Number1R01HD048730-01A2
Contact PI/Project LeaderSAPIENZA, CARMEN
Awardee OrganizationTEMPLE UNIV OF THE COMMONWEALTH
Description
Abstract Text
DESCRIPTION (provided by applicant): Involuntary infertility affects approximately one in ten couples, worldwide. This fraction of the population translates to a large number of individuals who are potential candidates for assisted reproductive technology (ART). In fact, more than a million children have been born as the result of in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) and children conceived by these procedures account for more than 1% of all births in several western countries. Despite the many reassuring reports on the safety of ART, there have been a small number of recent reports suggesting that ART children may be at increased risk for rare congenital malformation syndromes that are related to defects in genome imprinting. At least three children conceived by ICSI have been diagnosed with Angelman syndrome and at least 28 ART children (both IVF and ICSI cases) have been diagnosed with Beckwith-Wiedemann syndrome. The suggestion that ART children may be at modestly increased risk for rare, congenital disorders associated with defects in imprinting is troubling on two counts. The first is the obvious and direct impact of these particular syndromes on affected children and their families. The second, and more troubling, consideration is that these data may portend more widespread effects of ART on the establishment or maintenance of genome imprints, or other epigenetic marks, than can be assessed by screening for rare congenital abnormalities. For example, a strong association between sporadic colon cancer and constitutional loss of imprinting at the insulin-like growth factor 2 gene has been reported independently by two laboratories. The purpose of the proposed study is to determine whether ART increases the possibility of deregulated expression of imprinted genes and/or destabilizes epigenetic chromosomal marking. Seven measures of epigenetic chromosomal marking (DNA methylation at three differentially methylated regions, transcription of alleles at three imprinted genes, and X-chromosome inactivation ratios in females) will be analyzed on a population of 500 newborns conceived through ART and a control population of 500 newborns conceived in the traditional fashion. The incidence of abnormal epigenetic marks will be compared between the two populations to determine whether any aspect of the ART procedure results in destabilization of epigenetic structures in the genomes of early human embryos.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
DNA methylationandrogen receptorartificial fertilizationassistive reproductive techniquebiotechnologyclinical researchcord bloodepigeneticsfragile X syndromesfunctional /structural genomicsgenetic disordergenetic markersgenetic susceptibilitygenomic imprintinggrowth factor receptorshuman tissuein vitro fertilizationinsulinlike growth factornewborn human (0-6 weeks)placentasex linked traitsmall nuclear ribonucleoproteins
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
057123192
UEI
QD4MGHFDJKU1
Project Start Date
15-April-2006
Project End Date
31-March-2011
Budget Start Date
15-April-2006
Budget End Date
31-March-2007
Project Funding Information for 2006
Total Funding
$447,151
Direct Costs
$343,485
Indirect Costs
$103,666
Year
Funding IC
FY Total Cost by IC
2006
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$447,151
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01HD048730-01A2
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01HD048730-01A2
Patents
No Patents information available for 1R01HD048730-01A2
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01HD048730-01A2
Clinical Studies
No Clinical Studies information available for 1R01HD048730-01A2
News and More
Related News Releases
No news release information available for 1R01HD048730-01A2
History
No Historical information available for 1R01HD048730-01A2
Similar Projects
No Similar Projects information available for 1R01HD048730-01A2